Cashu
Crescent Biopharma: Summary Request for Content Needed
2 days ago
Stocks
Health Care
cbio
Crescent Biopharma
CBIO
+0.38 (+2.92%)
13.4
USD
At close at Jul 18, 20:39 UTC
Overview
Loading chart...
Key Stats
Market Cap
8.48M
Dividend Yield
0.00%
P/E Ratio
NaN
EPS
-0.59
Revenue
-
Avg. Volume
363.91K
Recently from Cashu
About
What does CBIO do?
GlycoMimetics, based in Rockville, Maryland, develops glycomimetic drugs to treat diseases influenced by carbohydrate biology, with candidates like Uproleselan for AML and GMI-1687 for subcutaneous use. The company went public in January 2014 and employs 35 people.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.